GL1X · GenesisL1 explorer

MolNFT v1 · #121248 · protein

Cetuximab Fab in complex with cyclic linked meditope

5HPM · Cetuximab Fab light chain: “Cetuximab Fab in complex with cyclic linked meditope”. X-ray diffraction, 2 ligands (CY3, NAG), 7 pockets (best druggability 0.72). MolNFT v1 #121248 on GenesisL1: 3D structure, binding sites and pockets…

PDB
5HPM
Type
protein
Length
878 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cetuximab Fab light chain; Cetuximab Fab heavy chain; Cyclic amidated, acetylated linked…
Ligands
CY3, NAG
Pockets
7 · best druggability 0.72

Structure

x-ray diffraction · 4 distinct chains · 7% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CCetuximab Fab light chainprotein2136% helix, 50% strand—
BCetuximab Fab heavy chainprotein2167% helix, 52% strand—
DCetuximab Fab heavy chainprotein2147% helix, 52% strand—
E, FCyclic amidated, acetylated linked meditopeprotein110% helix, 36% strand—

Ligands and binding sites

  • CY3 · 2-amino-3-mercapto-propionamide · ligand · 2 copies · chains A, E, C, F
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110970.720.76112CY3
23710.620.7848empty
33730.610.7747empty
42430.510.7551empty
51640.460.7633empty

Interfaces

9 interfaces between chains.

  • A–B · 1746 Ų buried · 13 hydrogen bonds · protein-protein
  • C–D · 1698 Ų buried · 15 hydrogen bonds · protein-protein
  • A–C · 830 Ų buried · 7 hydrogen bonds · protein-protein
  • A–E · 524 Ų buried · 10 hydrogen bonds · protein-protein
  • C–F · 523 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 4 covalent, 2 glycan, 2 modified (disulfide, covalent ligand, N-glycosylation, nonstandard).

Compared structures

  • 5HPM · Cetuximab Fab in complex with cyclic linked meditope · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.